Factors affecting disease-free survival in patients with human epidermal growth factor receptor 2-positive breast cancer who receive adjuvant trastuzumab

Author:                      

Publisher: Science Publishers

ISSN: 2049-9450

Source: Molecular and Clinical Oncology, Vol.3, Iss.5, 2015-01, pp. : 1109-1112

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content